BRCA1 and familial pancreatic carcinoma: Since BRCA1/BRCA2 are frequently mutated in PanNETs and are significant predictors of survival outcome in pancreatic cancer patients [22], we analyzed if BRCA1/2 CNVs could impact the PFS in PanNETs patients.